Situation
A biopharmaceutical company enrolling a phase 2 clinical trial in a very serious neurodegenerative disease wanted help to accelerate clinical trial enrollment.
The Approach
- Designed and implemented a compliant patient lead generation program targeting recently diagnosed patients
- Directed patients to a clinical trial website with a digital prescreener
- Activated the Adnexi Portal for 50 sites across the United States and Canada
Results
250
Patients completed pre-screen
52
Patients completed screening at an active site
24
Patients randomized in 9 months